TABLE 4.
Cause of death | No. of patients | No. of patients (%) |
---|---|---|
Malignant disease under study, or complication due to malignant disease under study | 332 | 55% |
Adverse event | 47 | 8% |
Second primary malignant disease, or complication due to second primary malignant disease | 76 | 13% |
Other / unknown cause (not assessable or insufficient data) | 144 | 24% |
In the cohort of 599 expired patients.